November 2015 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2015. This roundup includes the latest...
Clozapine Benefits Those With Tx-Resistant Schizophrenia
Clozapine already approved for use after other antipsychotics don't work
CDC: Cholesterol Levels Improving But More Work Needed
Adults aged 40 to 59 did not achieve Healthy People 2020 goals in 2011 to 2014
FDA Approves Empliciti for Multiple Myeloma
Monoclonal antibody works with another approved therapy to provide additional benefit
Neurotoxicity Seen With Acyclovir at Recommended Dose in Dialysis
Case report describes acyclovir-induced neurotoxicity in patient treated with recommended dose
Trimethoprim-Induced Aseptic Meningitis Described
Case report describes 87-year-old with 3 episodes; decreasing interval between dose, symptoms
Basal Insulin Peglispro Beats Glargine for Glycemic Control
In T2DM, also tied to increased triglycerides, aminotransferases, and liver fat content
Progesterone May Not Help Prevent Repeat Miscarriage
Live birth rate 65.8 percent for vaginal progesterone, versus 63.3 percent for placebo
FDA Approves First Flu Vaccine Containing an Adjuvant
Adjuvant can enhance or direct the immune response of the vaccinated individual
Topical Retinol Induces Skin Changes Similar to Retinoic Acid
Retinoic acid, retinol treatments both increase epidermal thickness, up gene, protein expression
